According to previous studies, dogs with HAC still exhibit persistent hypertension, elevated leptin and insulin levels, and incomplete resolution of proteinuria, hypercoagulability, and inflammatory markers despite trilostane treatment, which inhibits cortisol production and alleviates clinical symptoms. The gene discussed is INS; the disease is thrombophilia.